Number of shares and votes in Oncopeptides
Stockholm —October 31, 2018 — Oncopeptides AB (Nasdaq Stockholm, ONCO) today announces that the number of shares and votes in Oncopeptides has changed as a result of exercise of warrants under the company’s incentive programsThrough the exercise of warrants under the company’s incentive programs, the number of outstanding shares and votes will increase by 21,600 from 44,048,721 to 44,070,321. The share capital will increase by approximately SEK 2,400 from SEK 4,894,302 to SEK 4,896,702. For further information, please contact: Jakob Lindberg, CEO of OncopeptidesTelephone: +46 8 615